Brief: Oncocyte Announces Reduction In Force
12/04/2023 21:29
April 12 (Reuters) - OncoCyte Corp OCX.O :
* ONCOCYTE ANNOUNCES REDUCTION IN FORCE
* ONCOCYTE CORP - A REDUCTION IN FORCE INVOLVING
APPROXIMATELY 20%
OF ITS WORKFORCE, WHICH MANAGEMENT BELIEVES WILL EXTEND
ONCOCYTE'S CASH RUNWAY IN 2024
Source text for Eikon: ID:nGNX7J2nCJ
Further company coverage: OCX.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Insight Molecular Diagnostics
See all newsBrief: Insight Molecular Diagnostics Enters Amendment No. 2 To Merger Agreement On Sept 15, 2026
Insight Molecular Diagnostics Inc reports results for the quarter ended June 30 - Earnings Summary
Insight Molecular Diagnostics Inc expected to post a loss of 24 cents a share - Earnings Preview
Insight Molecular Diagnostics Q1 loss narrows as costs drop
Brief: Insight Molecular Diagnostics Completes Key Milestones Advancing Graftassuredx Toward FDA Submission